ABEO: Abeona Therapeutics Inc. Expected earnings per share growth for next year

Public company logo of abeonatherapeutics.com (ABEO)

Abeona Therapeutics (ABEO) management is currently actively scaling production capacities to bring its key product to market. The shift in the consensus net profit growth estimate visualizes these expectations, where the value of 55.20 corresponds to the current metric. The primary momentum is driven by the anticipated FDA approval of Pz-cel. Strong protection against dumping and exclusive sales rights guarantee the company a stable position within the orphan diseases niche.

Abeona Therapeutics, Inc. (ABEO): Net earnings per share change forecast for next year from 07/04/2022 to 11/17/2026

Analytical breakdowns and data insights for company Abeona (ABEO)

- share price and consensus valuation forecast:
Fundamental company valuation:ABEO, Abeona Therapeutics, Inc.
Finished products of Abeona Therapeutics, Inc.

This indicator assesses the expected dynamics of earnings per share, reflecting market expectations for business growth rates. By analyzing the consensus forecast for forward-looking EPS growth, an investor determines the probability of an asset valuation adjustment. The calculation is based on the aggregation of analysts' projected earnings relative to the current period. For Abeona Therapeutics (ABEO), this trend depends directly on the success of gene therapy and the volume of government grants.

Analysis of competing companies

VRTX (Vertex) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year ALNY (Alnylam)|Expected earnings per share growth for next year INSM (Insmed)|UTHR (United Therapeutics Corp) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year BioMarin BMRN|BBIO (BridgeBio Pharma Inc) - Net earnings per share change forecast for next year|BGM Group Ltd - Earnings growth forecast for next year|Expected earnings per share trend next year COGT (Cogent Biosciences)|XERS: Earnings growth forecast for next year|Keros Therapeutics Inc (KROS) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Arcturus Pharma|ETON: Expected earnings per share trend next year|Net earnings per share growth forecast for next year kamada.com (KMDA)|Expected earnings per share growth for next year Fulcrum Therapeutics FULC|Earnings growth forecast for next year MREO (Mereo BioPharma Group)|PLX (Protalix BioTherapeutics Inc.) - Net earnings per share change forecast for next year|PLRX - Net earnings per share growth forecast for next year|APLT - Earnings growth forecast for next year|RNTX: Earnings growth forecast for next year|Expected net earnings per share growth next year Gelteq Limited Inc (GELS)|Expected earnings per share growth for next year AYTU|Expected net earnings per share growth next year chemomab.com CMMB|Expected earnings per share growth for next year SRXH (SRx Health Solutions Inc)|PLRZ - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Aeterna Zentaris AEZS|Cyclo Therapeutics, Inc. (CYTH) - Expected net earnings per share growth next year|INZY - Net earnings per share growth forecast for next year|Expected earnings per share trend next year RPHM (Reneo Pharmaceuticals Inc.)|COSCIENS Biopharma Inc. (CSCI) - Net earnings per share growth forecast for next year